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Abstract
Hypertension is a major risk factor for cardiovascular 
disease, such as atherosclerosis, heart attack, and 
stroke. Surveys indicate that one out of four Americans 
has high blood pressure. It occurs more often in men than 
women and is most common in African-American males.
Despite the fact that there are constantly improving 
treatments available, many hypertensive patients are 
noncompliant with prescribed treatment plans. The focus of 
this descriptive study was to identify facilitators and 
barriers to compliance in hypertensive middle-aged African 
American adults. Pender's Health Promotion Model served as 
the theoretical framework. The research question guiding 
this study was as follows: What are the facilitators and 
barriers in regard to compliance in hypertensive middle- 
aged African-American adults? Utilizing convenience 
sampling, a questionnaire was presented to 50 middle-aged 
African-American adults who reside in the Delta area of a 
southeastern state. Data collected from the questionnaire 
were analyzed using descriptive statistics, such as means, 
frequency, and percentages. Analysis of the data found
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that 26% of the sample reported daily medication 
compliance. Thirty-one percent verified low-salt dietary 
modifications. Regular exercise was also confirmed by 56% 
of the participants. Subjects reported that the top two 
facilitators to hypertensive treatment compliance were 
adequate transportation to pick up medications and income 
or insurance to pay for medications, respectively. The two 
major barriers to hypertensive treatment compliance were 
"forgetting medication or not liking to take medication 
daily" and "not liking to exercise." The findings of this 
study indicated that respondents identified physical or 
external factors as the greatest facilitators to 
hypertensive treatment compliance. They also suggested 
that the primary barriers are internal or personal 
perceptions. Recommendations for further study include 
replication of this study with a larger sample size and 
more studies with a valid and reliable research tool as 
well as incorporation of teaching and learning strategies 
that effect compliance to medication treatment.
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Hypertension or high blood pressure is an 
international problem. Hypertension is a major risk factor 
for cardiovascular diseases, such as atherosclerosis, 
heart attack, and stroke. High blood pressure also can 
lead to other conditions, such as congestive heart 
failure, kidney damage, dementia, and blindness. 
Hypertension is defined as a blood pressure > 140/90 
(Kannel, 1996). Today approximately 24 million Americans 
are treated with antihypertensive drugs at an estimated 
annual cost of $15.5 billion {Jones, 2003). Despite the 
fact that there are treatments available, many 
hypertensive patients are noncompliant with prescribed 
treatment plans (Gabriel, Gagnon, & Bryan, 1997).
In the United States approximately 50 million people 
have hypertension (Jones, 2003). The prevalence increases 
with age and occurs more often in men than women. It is 
most prevalent in the African-American community (U. S. 
Department of Health and Human Services [DHHS], 2002) . 
According to Benson and Britten (2002), 50% of the people
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diagnosed as having hypertension do not take the drugs 
that, as prescribed, may benefit their health. The focus 
of this descriptive study was to identify facilitators and 
barriers to compliance in hypertensive middle-aged 
African-American adults.
Establishment of the Problem
Hypertension, known as the silent killer, is a major 
cardiovascular and cerebrovascular risk factor and 
condition which is very prevalent throughout the world 
involving 50% of those over 60 years of age (Mallion & 
Schmitt, 2001). The signs and symptoms of this condition 
can be very vague and include such symptoms as headaches, 
epistaxis, and blurred vision or no symptoms at all. Most 
hypertensive patients have no symptoms at all. Thus, it is 
difficult to get them to accept treatment or lifestyle 
changes that prevent cardiac events for the long term. The 
consequences of this chronic state can have devastating 
effects on different body systems which can lead to 
blindness, stroke, heart attack, and kidney failure. 
According to the DHHS (2002), over three quarters of women 
and 64% of men age 65 and over have hypertension. In 2000 
there were 17,964 deaths and 10,398,000 office visits 
attributed to hypertension in the United States (DHHS,
2002).
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African Americans develop hypertension at an early 
age and have a greater rate of severe hypertension 
(National Institutes of Health [NIH], 2001). African 
Americans in the southeastern United States have a greater 
incidence of high blood pressure as well as higher death 
rates resulting from strokes than any other area of the 
nation (NIH, 2001). Researchers have determined that 
simply being born in the southeastern United States can 
greatly increase a person's risk for stroke (Motolik,
2003). From 1991 to 1998, the state of Mississippi had 
14,117 residents over the age of 35 years who died from a 
stroke. This finding suggests that approximately 1,265 
deaths occur annually from strokes (Motolik, 2003).
Once the diagnosis of hypertension is made, 
adjustments in the patient's lifestyle must be made in 
order to manage the condition. Medical treatment usually 
includes one or more antihypertensive medications. The 
patient is usually placed on a low-sodium, low-fat, and 
low-cholesterol diet. Routine exercise and weight loss are 
encouraged. Smoking cessation, stress management, and 
decreased alcohol consumption are also advised. For a 
great number of patients, hypertensive treatment can 
encompass all of these modifications. Because so many 
facets of the patient's lifestyle require permanent
4
adjustment, true compliance becomes a serious issue 
(Bonner & Carr, 2002) .
As debilitating as the consequences are for 
noncompliant hypertensive patients, it would be easy to 
assume that compliance should be on an upswing. Gallup and 
Cotugno (1986) discovered that 11% of patients treated for 
hypertension stopped their medicines because of 
undesirable side effects, 25% because they thought that 
their doctor asked them to, 4 6% because they thought they 
had been cured, and 6% for financial reasons. Many 
patients may maintain compliance with one or two aspects 
of the treatment plan; however, few patients are compliant 
in all necessary areas (Mallion & Schmitt, 2001). 
Researchers have not been able to pinpoint one specific 
thing that causes or prevents compliance. Instead of just 
one thing, a variety of issues can be involved. Hayes 
(2001) reports that lack of information related to the 
disease process, treatment plan, expectations, and 
medications is a primary reason for lack of compliance. 
According to Mallion and Schmitt (2001), other influences 
of compliance include the patient, the treatment, the 
therapeutic environment, and the disorder. Hershey,
Morton, Braithwaite-Davis, and Reichgott (1980) identified 
control over health matters, perceived barriers, and 
duration of treatment as contributory factors to
5
compliance. More research is needed among the most 
affected populations to study what makes treatment 
compliance easier as well as what hinders or prevents 
treatment compliance. The purpose of this research was to 
determine if a relationship existed between facilitators 
and barriers to compliance with hypertensive treatment 
regimens.
Significance to Nursing
Research. The increased prevalence of hypertensive 
patients makes it necessary for family nurse practitioners 
(FNPs) and other health care providers to have a working 
knowledge of the issues surrounding compliance. Having a 
better understanding of what facilitates or inhibits 
treatment compliance for this population can foster 
guidance for the most effective treatment strategies to 
manage this chronic condition. This research study can add 
to nursing's body of knowledge to impact the overall goal 
of maintaining tighter control of the disease and 
increasing the quality and longevity of life for 
hypertensive patients.
Education. It is vital that nursing programs 
incorporate the importance of assessing facilitators and 
barriers to treatment compliance within course curricula 
at all levels of nursing education. Emphasis must be
focused on changing or modifying behaviors to ensure 
compliance with treatment, thus promoting health and 
compliance. Another important educational aspect is that 
this study can provide understanding of patient behavior 
which can be helpful in educating patients on ways of 
enhancing treatment compliance.
Practice. Because this devastating condition has such 
serious consequences, nurse clinicians must continue to 
evaluate reasons for noncompliance. Nurse practitioners in 
primary care are constantly faced with the challenge of 
prescribing hypertensive treatment..It is important that 
health care providers know facilitators and barriers to 
compliance with these treatment regimens. The results of 
this study could provide pertinent insight in the problem 
of noncompliance with hypertension and thereby improve 
patient response to treatment of this chronic condition.
Theory. Pender's Health Promotion Model validates the 
need for promoting health through the use of assessing 
behaviors and beliefs (Tomey & Alligood, 2002). Therefore, 
nurse clinicians should consider this model as a 
significant framework choice for practice. Pender suggests 
that individual beliefs about health influence the 
likelihood of participation in health-promoting behaviors. 
Health behaviors are linked to health promotion. This is a 
primary goal for health care providers. This study adds to
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Pender's Health Promotion Model and the body of nursing 
knowledge by supporting that a patient's personal beliefs 
about facilitators and barriers to compliance have an 
influence either directly or indirectly on participation 
in health-promoting behavior, such as adherence to a 
prescribed treatment regimen.
Theoretical Framework
The theoretical framework for this study was Pender's 
Health Promotion Model. Within this model specific 
behaviors related to health-promoting lifestyles were 
examined. Individual characteristics and experiences, 
cognitive and perceptual factors of perceived benefits, 
and perceived barriers to determine behavioral outcomes 
also were identified (Tomey & Alligood, 2002).
The Health Promotion Model is reflective of nursing 
and behavioral sciences and is built on seven assumptions 
and 14 theoretical propositions. Pender suggested that 
people have a desire for well-being which acts as the 
primary motivator for health promotion. Pender further 
concludes that individual stimulation to participate in 
health-promoting behaviors is an intricate process. All of 
these factors are applicable and provide a broad base for 
possibly unraveling the issue of compliance in 
hypertensive patients.
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The major concepts of Pender's model are prior 
related behaviors and personal factors. Prior behaviors 
also encompass inherited and acquired characteristics. The 
personal factors entail biological, psychological, and 
sociocultural factors. The behavior specific cognitions 
and affect are made up of six distinct divisions (Pender, 
Murdaugh, & Parsons, 2002). Basically, according to Pender 
et al., if a person feels that he or she will benefit from 
behavior change, if he or she believes achievement of the 
behaviors is possible, then he or she will commit to a 
plan of action. The more positive the person's feeling are 
about the plan, the greater the commitment to the plan. 
These are important concepts for the hypertensive patient 
because the plan for control is multifaceted and long­
term.
In this present study the researcher examined the 
relationship between facilitators and barriers and 
compliance with hypertension treatment regimens in middle- 
aged African-American adults. Since individual 
circumstances and perceptions vary, client's personal 
beliefs about health have an influence either directly or 
indirectly on participation in health-promoting behavior, 
such as adherence to a prescribed treatment regimen. The 
cognitive-perceptual factors and modifying factors of an
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individual may determine the likelihood of participation 
in health-promoting behavior (Pender et al., 2002).
Statement of the Problem
The overwhelming evidence from the literature 
suggests that hypertension and its untoward effects are on 
the rise and part of the problem could be that 
hypertensive patients are noncompliant with prescribed 
treatment plans. The incidence and devastating effects of 
this condition appear more profoundly in the African- 
American community (DHHS, 2002). Presently there is a 
limited amount of literature concerning the facilitators 
and barriers to compliance in hypertensive middle-aged 
African-American adults. Through this study the researcher 
identified facilitators and barriers to compliance in 
hypertensive middle-aged African-American adults.
Research Question
This study explored one question: What are the 
facilitators and barriers to compliance in hypertensive 
middle-aged African-American adults?
Definition of Terms
The theoretical and operational definitions for the 
terms used in this study are as follows:
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Facilitator: The theoretical definition means to make 
easy or enhance action {Webster's Classic Reference 
Library Dictionaryf 1999). The operational definition for 
this study is any value, belief, or action that encourages 
or fosters compliance to hypertension management as 
determined by the Jones Hypertensive Compliance Survey.
Barrier: The theoretical definition means anything 
that hinders or blocks action or impediment to progress 
{Webster's Classic Reference Library Dictionary, 1999).
The operational definition for this study is anything that 
hinders compliance with hypertension management as 
determined by the Jones Hypertensive Compliance Survey.
Compliance : The theoretical definition refers to 
cooperative performance or adherence to prescribed therapy 
or medications (Mallion & Schmitt, 2001). The operational 
meaning refers to adherence to prescribed antihypertensive 
medications, dietary restrictions, and exercise regimen as 
determined by the Jones Hypertensive Compliance Survey.
Hypertensive : Theoretically, this term means a 
condition in which the blood pressure is found to be 
higher than 140/90 mm Hg on two occasions after the 
initial screening (Christensen & Kockrow, 2003). 
Operationally, this term refers to a condition in which 
the blood pressure has been consistently higher than 
140/90 mm Hg and the person has been prescribed blood
11
pressure medications and or other treatments to lower 
blood pressure.
Middle-aged African-American adults: The theoretical 
definition refers to any United States citizen of African 
heritage age 40 to 65 years old. The operational meaning 
is any United States citizen of African heritage, male or 
female, between the ages of 30 and 50 years who attend the 
church involved in this study.
Assumptions
For the purpose of this study, the following 
assumptions were made :
1. Hypertension in middle-aged African-American 
adults is a significant health problem.
2. Facilitators and barriers influence compliance to 
hypertensive treatment.
3. Health-promoting behavior is influenced by 
perceptions about health.
Summary
The incidence of hypertension among the African- 
American population is disproportionately greater than 
other races (DHHS, 2002). Along with this chronic 
condition comes the potential of many other debilitating 
and life-threatening illnesses. Despite the many 
treatments available, compliance with the treatment plans
12
continues to baffle health care providers. Therefore, this 
study was conducted to identify facilitators and barriers 
to hypertensive treatment compliance.
Chapter II 
Review of the Literature
Hypertension is a medical condition that is 
associated with many other cardiovascular diseases, such 
as atherosclerosis, heart attack, and stroke (National 
Institutes of Health, 2001). Hypertension cannot be cured, 
but it can be controlled by adherence to prescribed 
medications and or diet and exercise (Jones, 2003).
Despite the vast number of treatment options available, 
hypertension management continues to elude health care 
professionals. The causes of this baffling fact vary. Lack 
of compliance has been identified as one major 
contributing factor to poor management (Mallion & Schmitt, 
2001).
Bonner and Carr (2002) conducted a study on 
medication compliance problems in general practice : 
detection and intervention by pharmacists and doctors. The 
problem of medication compliance was referred to as a 
complex problem in health delivery which can lead to 
adverse outcomes and expensive medical care costs. Bonner 
and Carr (2002) sought to verify if a medication summary
13
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card would improve compliance. Further, they evaluated the 
role of a medical practice-based clinical pharmacist in 
identifying medication related problems in a rural general 
practice setting. The research was guided by two 
questions :
1. What are the effects of patients carrying a card 
noting medication and medical history on 
compliance?
2. What are the effects involving a clinical 
pharmacist on compliance?
Compliance was defined as the extent to which a 
person's actions are reflective of medical 
recommendations. Noncompliance was defined as omitting 
prescribed medications, taking nonprescribed medications, 
as well as altering prescribed dosage and or frequency.
This quantitative, experimental study was implemented 
in a small rural Australian community with only one 
physician and one community pharmacist. A collaborative 
model was used in this study. The sample {N = 50) 
consisted of consent patients who presented for surgery, 
had four or more prescribed medications, and a significant 
medical history. Forty-eight of the selected patients were 
over 65 years of age. The living arrangements for the 
selected patients were as follows : 45% lived with a 
partner, 10% lived alone, and the remainder lived in
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shared accommodations. There were equal numbers of men and 
women.
A medication summary card was specifically structured 
for the purposes of this study. This card included a 
summary of the patient's medical problems and medical 
regimen. Space was also provided for new medical problems, 
medication changes, and herbal or alternative therapy 
being consumed by the patient. The clinical pharmacist was 
given the patients' medical records and conducted 
individual interviews with each patient. The patients 
brought their medications to the session. Basic medication 
information was noted including frequency, timing, 
forgotten medications, and adverse medication reactions. 
Reasons for discrepancies between current medications and 
those listed in the health summary as well as patient 
perception of effectiveness of medications were also 
documented.
The data collection procedure was conducted in a 
12-month period. A group of participants was initially 
interviewed by the general practitioner (GP), and data 
were classified into seven categories. This data 
distribution included (a) full compliance with 
medications, (b) dose or frequency discrepancies, (c) not 
taking prescribed medications, (d) taking medication 
unknown to physician, (e) information to pharmacist but
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physician unaware, (f) potential clinical problems noted 
by the pharmacist, and (g) medication choice, dose, or 
timing changed in response to intervention. Next, the 
subjects were given the medical summary card and 
subsequently followed up with sessions with the clinical 
pharmacist and the physician. Any discrepancies with 
medical treatment found by the pharmacist were forwarded 
to the physician who followed up with the patients, and 
any necessary changes were written on the card. The 
patients were to take the card with them to all health 
care appointments.
Bonner and Carr (2002) found overall the average 
number of medications per subject was 6.5. Six patients 
used over 12 medications, and 32% of the prescribed 
medications were for a diagnosis of a cardiovascular 
problem. There was a 40% level of noncompliance. Four 
percent of the patients were not taking prescribed 
medication. Twenty percent were either noncompliant with 
dose and or frequency or taking medications unknown to the 
physician.
No patients were noncompliant related to physical 
ailments. Compliance with medications was not influenced 
by the number of medications patients used or patient's 
living arrangements. Fifty percent of the patients had 
clinical issues raised by the pharmacist. The physician
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followed up and acted on 16% of the clinical issues and 
changed medications for 8%.
Bonner and Carr (2002) concluded that the medical 
summary card was insignificant in increasing the level of 
medication compliance. The researchers suggested the 
importance of practitioners being aware of patients' 
comprehension and communication levels. The researchers 
recommended that the role of the clinical pharmacist be 
studied with a larger group. The study by Bonner and Carr 
(2002) is germane to the current researcher's endeavor as 
it reconfirms that medication compliance is a complex 
problem that mandates further exploration.
In another study, Allen (2002), sought to identify 
persons with high blood pressure and evaluate 
correlational factors as well as to identify barriers to 
care in a rural area. Correlational factors were defined 
as age, gender, regular blood pressure screenings, 
familial tendency, and taking antihypertensive 
medications. Regular blood pressure screenings were 
defined as once every 2 years.
Pender's Health Promotion Model was utilized for this 
study because it identified behaviors of health. The 
Health Promotion Model suggests that the optimal health of 
a person is the goal of nursing care. This model focuses 
on cognitive-perceptual factors, such as importance of
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health, definition of health, perceived health status, and 
perceived benefits and barriers to health promotion. These 
factors are affected by personal, situational, and 
interpersonal characteristics, such as age, gender, 
education, income, body weight, family patterns of health 
care behaviors, and expectations of significant others.
All of these concepts directly influence the importance of 
health, perceived benefits of health, and perceived 
barriers to health-promoting behavior (Pender et al.,
2002).
This study by Allen (2002) was a descriptive- 
correlational study. A convenience sample {N = 50) was 
chosen in a southern town supermarket. Blood pressure 
screening was done. The volunteers also completed a 
researcher-developed survey. Fifty-seven men and women 
participated in the screening with ages ranging from 20 to 
86 years. Fifty of these participants were utilized in 
this study. Exclusion criteria included those less than 18 
years of age and or unavailability of appropriate blood 
pressure cuff.
The findings of the study were numerous. Sixty 
percent of the participants were older than 55 years, 20% 
were 46 to 55 years, 8% were 36 to 45 years, 2% were 25 to 
35 years, 6% were 18 to 24 years, and 4% did not give 
their age. Females made up 60% of the participants.
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Seventy-two percent reported having regular blood pressure 
screenings. Twenty-eight percent were found to have 
elevated blood pressure. Forty-six percent of those with 
hypertension lacked the incidence of familial 
hypertension. Maternal hypertension was noted in 42%.
All participants reported having their blood pressure 
checked previously. Twenty-eight reported never previously 
receiving blood pressure teaching. Eighty-six percent 
sought health care regularly, and 7 6% denied difficulty in 
accessing health care. Eighty percent knew of a local 
health care provider. Only 4% verified problems with 
transportation to health care. Sixteen percent reported 
financial concerns interfering with regular health care 
visits.
This study concluded that persons over 55 years of 
age were more likely to take blood pressure medications. 
There was a correlation between transportation and money 
concerns. This incidence of hypertension in a rural 
community did not vary significantly from the national 
average. This study also confirmed the importance of 
community education regarding hypertension. The researcher 
recommended that this study be done on a larger scale to 
determine if maternal hypertension could be used as a 
marker for risk to the researcher's offspring. Efforts to 
evaluate and educate should be ongoing in primary
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practice. Allen's (2002) research is also germane to the 
current researcher's endeavors because it supported the 
prevalence of hypertension and perceived barriers to 
treatment.
Gabriel, Gagnon, and Bryan (1997) conducted a 
controlled study examining the use of a daily drug 
reminder chart with concurrent pharmacist supervision.
This 14-week study took place at a pharmacy in a community 
health center in a southern state. The 7 9 participants of 
this study were aged 50 years and older with a diagnosis 
of hypertension of at least one year's duration and a 
history of taking two or more chronic prescription 
medications. Participants were predominantly black females 
with a mean age of approximately 65 years old with lower 
educational and income levels. Subjects were required to 
complete three monthly clinic visits during which 
compliance was measured by pill counts and objective 
interviews to assess patient knowledge and adherence to 
their drug regimen.
Baseline compliance data were collected by the 
researchers on all patients, then the groups were randomly 
assigned to either Group A and Group B. The pharmacist 
discussed the use and administration of each drug with 
each participant in both groups. Group A received a daily 
drug reminder chart while Group B did not receive a daily
21
drug reminder chart. This chart included the drug name, 
dose, use, and time(s) of administration. Group A 
participants were encouraged to mark the plastic-enclosed 
chart with a pen as each medication dose was taken. During 
the second monthly visit, pill counts and interviews were 
conducted in both groups. Group B was then given a daily 
drug reminder chart to determine the effect on compliance.
The researchers reported that 8 9% of the patients 
were taking a diuretic, 65.8% were on at least one 
specified antihypertensive medication, and 30% were taking 
a potassium supplement. Visit one showed no significant 
difference between Groups A and B with 65.8% and 66.4% 
mean group compliance score, respectively. At the second 
visit there was a 16% increase in the mean compliance of 
the chart group versus a 4% increase for the non-chart 
group. There were twice as many compliance scores of 90% 
or better among those patients receiving a daily drug 
reminder chart. Improvement in patient knowledge of drug 
use, dose, and frequency of administration was evident 
among chart recipients. Data also revealed a decrease in 
regimen deviation among chart recipients to 27% versus 75% 
in the non-chart group. Errors from forgetfulness also 
declined in the chart group as compared to the non-chart 
group by 61% and 21%, respectively.
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This study revealed that better drug compliance is 
enhanced with verbal instructions and reinforcement of a 
drug reminder chart. The findings also showed that good 
communication of instructions and information to patients 
decrease drug errors and promote better compliance. This 
study also emphasized the vital role the pharmacist can 
play in promoting compliance. The researchers revealed 
that treatment compliance can be affected by different 
things and enhanced by minimal interventions. This 
evidence supports the researchers' question.
Benson and Britten (2002) conducted a qualitative 
study using interviews to describe the way in which 
antihypertensive patients decide whether or not to take 
their medications. This study took place in the United 
Kingdom in two urban practices. Thirty-eight patients were 
selected on the basis of receiving repeated prescriptions. 
Participant age, sex, years taking antihypertensive 
medication, type and number of antihypertensive 
medication, number of non-antihypertensive drugs 
prescribed, and number of repeated prescription records 
all varied. The patients were interviewed in their homes 
with questions based on a topic guide from existing 
studies.
Seventy-six percent of the patients in this study 
expressed some reservation concerning taking medications.
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However, all the subjects held perceptions in favor of 
taking the drugs. Sixteen interviewees voiced concerns 
about the unnatural or unsafe aspects of medications.
There were several specific reasons for reservations about 
antihypertensive drugs. These reservations included (a) 
desire to discontinue using antihypertensives, (b) 
preference for an alternative to drugs, (c) patient 
questioned continued necessity, and (d) possible long-term 
or hidden risks. Positive experiences with doctors cited 
included advice from doctors, trust in doctors, and 
improved blood pressure readings. The subjects reported 
feeling better, having peace of mind, and achieving a good 
outcome as benefits of antihypertensive drugs.
Several limitations of this study were addressed. 
Patients who had discontinued treatment before the study 
were not included. There was also a lack of ethnic 
minorities in the sample used. The fact that this was a 
cross-sectional study can be considered somewhat limiting. 
Even with these limitations this was a very informative 
study that verified the fact that patients do sometimes 
have reservations about medications. The researchers also 
pointed out that these reservations may have no bearing on 
the drug's pharmacology. In essence, the researchers 
showed that by talking to patients and considering their 
views when initiating antihypertensive treatment, it is
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possible that the problem of noncompliance can be 
curtailed. This study demonstrated actual barriers to 
hypertension medication compliance which is germane to the 
current researcher's endeavor.
Al-Sowielem and Elzubier (1998) conducted a cross- 
sectional study in Saudi Arabia which investigated 
compliance of hypertensive patients and patients' 
knowledge and misconceptions about hypertension.
Compliance in this study involved not only taking the 
prescribed medications but also adherence to follow-up 
appointments and maintaining the recommended lifestyle 
modifications. The sample included 190 hypertensive 
patients attending four primary health care centers. Each 
of the subjects had essential hypertension for at least 
one year and were registered in the primary health care 
centers. The mean age of the participants was 4 9.9 years. 
Patients were interviewed by training interviewers 
utilizing a structured questionnaire which encompassed 
demographic data as well as information pertaining to 
hypertension diagnosis, medications, compliance 
difficulties, regularity of follow-up, and consistent 
physician follow-up visits. Other data were also 
collected, including weight, height, body mass index 
(BMI), and blood pressure (BP). Compliance was measured in
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two ways: (a) BP measurements with diastolic blood
pressure of < 90 mm Hg and (b) self-reporting method.
The diastolic blood pressure method found 34.2% of 
patients were compliant while the self-reporting method 
revealed 74.7% compliant. Older patients and illiterate 
patients tended to be more compliant than those educated 
and younger. No significant difference was shown between 
males and females. The presence or absence of difficulty 
with compliance, number of drugs taken for hypertension, 
method of diagnosis of hypertension, and presence or 
absence of other chronic diseases did not significantly 
affect compliance rate. Overall, this study clearly 
revealed the importance of regular follow-up in achieving 
better compliance, emphasizing the need for health 
education to enforce this habit.
The studies reviewed and elaborated on the current 
researcher's question. Each study uniquely reflected upon 
facilitators, barriers, or treatment compliance. Even 
though the studies were different, the results were 
similar and specifically related to facilitators and 
barriers to compliance with hypertension.
Chapter III 
The Method
Hypertension is a major risk factor for 
cardiovascular diseases, such as atherosclerosis, heart 
attack, and stroke (National Institutes of Health [NIH], 
2001). Surveys indicate that one out of four Americans 
have high blood pressure (NIH, 2001). This disease occurs 
more often in men than women, and it is most prevalent in 
the African-American community (DHHS, 2002). Even with the 
vast number of treatments available, many hypertensive 
patients are noncompliant with prescribed treatment plans. 
The reasons for this noncompliance vary. Therefore, this 
descriptive study focused on identifying facilitators and 
barriers to compliance in middle-aged African-American 
adults with hypertension.
Design of the Study
A descriptive design was utilized in this study to 
identify possible facilitators and barriers to compliance 
in middle-aged African-American adults with hypertension. 
The primary focus of a descriptive design includes "the
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accurate portrayal of an individual's characteristics, 
situations or groups and the frequency with which certain 
phenomena occur" (Polit & Hungler, 1995, p. 134). 
Descriptive design allows the researcher the opportunity 
to observe, describe, and perhaps classify phenomena.
Variables
The categorical variables of interest in this study 
were the facilitators or barriers to a patient's choice of 
compliance to hypertensive treatment. The controlled 
variables were presence of hypertension, age, and actual 
compliance. Intervening variables were the patient's 
number of years as hypertensive, present state of physical 
health, and false responses to the questionnaire.
Research Question
This study explored one primary question: What are 
the facilitators and barriers to compliance in African- 
American middle-aged adults with hypertension?
Setting, Population^ and Sample
The setting was a rural community church in the Delta 
area of a southeastern state. The target population was 
African-American males or females aged 30 to 50 years who 
have been diagnosed with hypertension. The sample included 
all those who met the following criteria : (a) age 30 to 50
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years of African-American descent, (b) resided in the 
Delta area of a southeastern state, (c) diagnosed with 
hypertension and currently prescribed antihypertensive 
medications, and (d) willing to participate in this study. 
A target sample size of 50 was selected from the target 
population who met the criteria.
Methods of Data Collection
After obtaining approval from Mississippi University 
for Women's Committee on Use of Human Subjects in 
Experimentation (see Appendix A), approval was granted 
from a Delta area church's pastor (see Appendix B) after 
the researcher visited the church. The researcher visited 
the Delta area church and secured the sample. Only one 
Delta area church with approximately 500 members was 
utilized to obtain the sample. The pastor introduced the 
researcher to the congregation and requested that those 
church members who met the criteria stay after the church 
service. The researcher further elaborated on the study 
and verified that those remaining did meet the prescribed 
criteria. Those who were willing to participate remained. 




A verbal explanation of data collection information 
was provided, and verbal consent was obtained from the 
participants. The researcher handed out the questionnaire. 
After the participants completed the questionnaire, it was 
returned to the researcher.
The instrument, Jones Hypertensive Compliance Survey 
(see Appendix D), was researcher-developed. This 
instrument consisted of 16 total questions inclusive of 
six demographic items which included data related to age, 
height, weight, marital status, educational level, and 
annual income. The next group of six questions were 
specific to hypertension and consisted of information 
which focused on length of time diagnosed with 
hypertension and taking medications, the names of the 
medications, special diets, and or exercise practices. 
There was one visual analog which allowed for the 
participant's opinion of his or her existing health 
status. For example, if the participant felt his or her 
health status was poor, he or she would indicate this by 
placing an "X" on the left side of the line on the visual 
log. Another question provided each subject the 
opportunity to select as many facilitators and or barriers 
that were applicable to his or her personal situations.
The last two statements were open-ended questions which
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allowed the participant, in his or her own words, to 
describe anything that encouraged or hindered hypertensive 
treatment compliance.
Methods of Data Analysis
Descriptive statistics were utilized to analyze data 
and describe any relationship between variables. Responses 
to Questions 1 through 12 mandated fi11-in-the-blank, yes- 
no, or check (^) answers. These answers were reported by 
percentages and central tendencies. Question 13 was a 
visual analog which required an "X" response scored as a 
percentile on a lOO-mm line. Question 14 was divided into 
sections A and B which required participants to check all 
responses that applied. The most frequently selected 
responses from sections A and B were ranked in first 
through fifth places. Questions 15 and 16 requested 
subject opinion which was reported in narrative form. No 
summative score was possible, thus an item-by-item 
analysis was done.
Summary
The overall aim of this study was to describe 
facilitators and barriers to compliance with hypertension. 
The target population was middle-aged African-American 
males or females aged 30 to 50 years diagnosed with 
hypertension. The sample was Delta area residents of a
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southeastern state who met the criteria. A researcher- 




The purpose of this descriptive study was to assess 
facilitators and barriers to compliance in middle-aged 
African-American adults with hypertension. Identification 
of these factors will assist primary care providers, 
especially physicians and advanced practice nurses, in 
prescribing the most appropriate treatment regimens. Data 
were collected utilizing a researcher-developed survey to 
solicit demographic information and assess the factors 
that aid or impede the patient's compliance with 
hypertension treatment regimens in middle-aged African- 
American adults. The surveys were distributed in the Delta 
area of a southeastern state. Data were collected in a 
church setting within the community.
In this chapter, data collected and analyzed for this 
study are presented. Characteristics of the participants 
are described first, followed by the outcomes of the data 
analysis related to the research question and additional 




Description of the Sample
The convenience sample {N = 50) included participants 
meeting the criteria who visited the church between May 4, 
2003, and May 25, 2003. The age range of the subjects was 
32 to 50 years. The majority (76%) of the sample were 
women. Demographic data related to distribution of the 
sample by age and marital status are presented in Table 1.
Table 1
Distribution of the Sample for Age and Marital Status 
Expressed in Frequency and Percentage








Married 8 67 . 0
Single 3 25.0
Widowed 1 8 . 0
Females**
Married 21 55. 0
Single 14 37.0
Widowed 3 8 . 0
Note. Percentages were rounded to the nearest lÔ h.
= 50.
*n = 12. **n = 38.
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The majority of the participants had attended college 
(46%). There was a wide variation of annual mean income. 
Distribution of the sample by education and income can be 
seen in Table 2.
Table 2
Distribution of Sample for Education and Income Expressed 
in Frequency and Percentage
Variable f̂ %
Education
8̂*̂ grade or less 0 0.0
9'̂'̂ to 12^^ grade 7 14 . 0
High school graduate 15 30.0
Attended college 5 1.0
Graduated college 23 46.0
Annual family income
Less than $12,000 2 4 . 0
$12,001 - $20,000 8 16.0
$20,001 - $30,000 13 26.0
$30,001 - $40,000 15 30.0
$40,001 - and higher 12 2 4 . 0
= 50.
Thirty-six (72%) of the subjects reported having 
hypertension and taking medication for less than 5 years, 
while 28% confirmed this diagnosis for more than 5 years. 
Thirteen (26%) of the sample population affirmed taking 
their antihypertensive medication(s) every day. The number
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and type of antihypertensive medication(s) varied. Six 
participants gave no response to the question. A 
description of the medication, such as "a little white 
pill," was given by two subjects. Seventeen (31%) subjects 
reported a low-salt diet while the remainder of the group 
denied a special diet. Regular exercise was reported by 28 
(56%) of the sample population.
Results of Data Analysis
This research sought to answer one research question: 
What are the facilitators and barriers to compliance in 
hypertensive middle-aged African-American adults? Question 
14 of the Jones Hypertensive Compliance Survey presented 
nine facilitators and nine barriers to the participants.
The facilitators most commonly identified as the 
greatest help to achieving compliance were, "I have 
transportation to pick up my medication from the pharmacy" 
and "I have income/insurance to pay for my medication."
The majority of the participants reported understanding 
their medications, exercise plan, dietary restrictions, as 
well as the effects of hypertension on their bodies. Fewer 
than half of the subjects acknowledged a regular exercise 
schedule. Less than one third of the group reported 
compliance with taking prescribed medications daily and 
reading food labels to inquire about the amount of sodium.
36
fat, and cholesterol. The least chosen facilitator was,
"My doctor or nurse practitioner will praise me if I 
follow my prescribed treatment plan." Table 3 lists the 
facilitators identified by the participants of this study 
in rank order and then by the number and percentage of 
responses to each question.
Table 3
Rank Order of Facilitators to Hypertensive Treatment 
Compliance in African-American Middle-Aged Adults 
Expressed in Frequency and Percentage
Rank Variable f̂ %
1 I have transportation to pick 
up my medication from the 
pharmacy. 46 92.0
2 I have income/insurance to 
pay for my medication. 42 84 . 0
3 I understand how high blood 
pressure can affect my body. 40 80.0
4 When I take my medication(s), 
exercise, or eat according to 
my dietary restrictions, I feel 
good about myself. 36 72.0
5 I understand my medication(s) , 
exercise plan, and dietary 
restrictions prescribed by my 
doctor or nurse practitioner. 32 64 . 0
6 I exercise for at least 30 





7 I understand how important it is 
to take my medication(s) , so I 
take my medication(s) every day. 13 26.0
8 I read the labels on foods to 
find out the amount of sodium 
(salt), fat, and cholesterol 
amounts. 12 24.0
9 My doctor or nurse practitioner 
will praise me if I follow my 
prescribed treatment plan. 10 20.0
= 50.
The barriers most commonly identified as the greatest 
hindrance to achieving compliance were, "I do not like 
having to have to take medication every day or I forget to 
take my medicine(s)," "I do not like to exercise," and "I 
can't eat my food without salt and a little salt won't 
hurt." Less than one third of the participants reported 
inability to afford food on their prescribed diet plan, 
denied the seriousness of missing medications, and 
reported being tired or sick to exercise. The least chosen 
barriers were related to medications making subjects feel 
bad, lack of money, and transportation to purchase 
medications. Table 4 lists the barriers to hypertensive
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treatment compliance in rank order and then by number and 
percentage of responses to each question.
Table 4
Rank Order of Barriers to Hypertensive Treatment 
Compliance in African-American Middle-Aged Adults 
Expressed in Frequency and Percentage
Rank Variable f̂ %
1 I do not like having to take 
medication every day or I forget 
to take my medication. 28 56.0
2 I do not like exercise. 24 48 . 0
3 I can't eat my food without salt 
and a little salt won't hurt. 17 34 . 0
4 I can't afford the low-fat, low- 
sodium, and low-cholesterol foods 
on my diet plan. 15 30.0
5 It doesn't hurt if I miss a few 
doses of my medication. 13 26.0
6 I'm too tired or sick to exercise. 12 24 . 0
7 My blood pressure medications make 
me feel bad. 9 18.0
8 I don't have the money/insurance 
to pay for my medication. 6 12.0
9 Sometimes I don't have 
transportation to pick up my 




The Jones Hypertensive Compliance Survey allowed the 
participants to rank their health status using a visual 
analog on a scale of 0 to 10, with 0 being unhealthy and 
10 being very healthy. The mean health score was 6.5 with 
64% [n = 32) of the participants ranking their health from 
6 to 10, 34% (n = 17) ranking their health less than 6,
and 2% (n = 1) did not answer this question. This score 
represented how they ranked their overall health status on 
the date that the survey was completed.
Subjects were also allowed to complete two open-ended 
questions on the Jones Hypertensive Compliance Survey. The 
first question was, "What do you think is your greatest 
help in keeping to your hypertensive health plan?" Twenty 
(40%) of the participants responded to this question. The 
following are examples of subjects' responses.
I want to live.
I don't want to get sick.
I need to be here for my family.
The second open-ended question was, "What do you 
think is the greatest barrier to keeping to your 
hypertensive health plan?" Thirty-seven (74%) of the
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subjects responded to this question. The responses 
included the following:
That medicine is too high.
I just don't have time.
I forget about it.
Summary
Findings from this descriptive study revealed a 
sample {N = 50) with a mean age of 4 0.6 years. The 
majority of the participants (n = 38) were women. Twenty- 
nine participants were married. All of the participants 
were prescribed medication as part of their hypertensive 
treatment regimen. Thirteen of the participants reported 
taking their medications every day.
Chapter V 
The Outcomes
The purpose of this study was to identify 
facilitators and barriers to compliance with hypertensive 
treatment in African-American middle-aged adults. Pender's 
Health Promotion Model was used as the framework for this 
study. Data were collected using a researcher-designed 
survey. Descriptive statistics were used to analyze 
demographic data. Frequencies and percentages were used to 
identify prominent facilitators and barriers in the Jones 
Hypertensive Compliance Survey. Content analysis was 
performed on the open-ended questions. This chapter will 
include a discussion of the findings, conclusions, 
implications for nursing, and recommendations for future 
research.
Summary of Findings
The sample consisted of 50 middle-aged African- 
American adults, aged 32 to 50 years, with histories of 
hypertension. The mean age was 40.6 years. The sample was 
76% female and 24% male. Fifty-eight percent of the
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subjects were married, and 4 6% of the participants 
reported attending some college. Thirty-nine percent of 
the group were high school graduates or stopped school 
between the ninth and 12^^ grades. The remainder (46%) of 
the subjects reported attending some college. Thirty 
percent of the respondents reported an annual family 
income between $30,000 and $40,000. Seventy-two percent of 
the participants reported being hypertensive for 5 years 
or less, while 28% confirmed the diagnosis of hypertension 
for greater than 5 years. Twenty-six percent confirmed 
taking their antihypertensive medication every day. A low- 
salt diet was reported by 31% of the subjects. The 
following research question guided the study: What are the 
facilitators and barriers to compliance in hypertensive 
middle-aged African-American adults?
Discussion
The findings of the current study supported the use 
of Pender's Health Promotion Model (Pender et al., 2002) 
to explain the determinants of health-promoting behaviors, 
such as compliance with hypertensive treatment regimens. 
This study focused on treatments inclusive of medications, 
diet, and exercise. Since individual circumstances and 
perceptions vary, client's personal beliefs about health 
have an influence either directly or indirectly on
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participation in health-promoting behavior, such as 
adherence to a prescribed treatment regimen. The 
cognitive-perceptual factors and modifying factors of an 
individual may determine the likelihood of participation 
in health-promoting behavior (Pender et al., 2002). These 
factors can be referred to as facilitators which enhance 
action and barriers which can hinder or block action.
The facilitators most commonly identified as the 
greatest help to achieving compliance were, "I have 
transportation to pick up my medication from the pharmacy" 
and "I have income/insurance to pay for my medication." In 
Allen's (2002) study, which sought to identify persons 
with high blood pressure and evaluate correlational 
factors as well as to identify barriers to care in a rural 
area, it was found that only 4% of 50 participants 
reported problems with transportation, and 16% reported 
financial concerns interfering with regular health care 
visits. This is supportive of the current research study. 
These findings could be attributed to the sample 
population's financial status and or the fact that the 
subjects resided in a small town and the pharmacies were 
easily accessible.
The third and fourth ranked facilitators were, "I 
understand how high blood pressure can affect my body" and 
"When I take my medication(s), exercise or eat according
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to my dietary restrictions, I feel good about myself." It 
seemed quite ironic that participants would report 
understanding the effects of high blood pressure while 
only 13 subjects reported daily compliance. It is possible 
that the participants did not want to admit a lack of 
understanding of hypertension. Hayes (2001) reported that 
lack of knowledge related to the disease process, 
treatment plan, expectations, and medications is a primary 
reason for lack of compliance. Both of these facilitators 
are representative of internal or personal variables. The 
fourth ranked variable also seemed somewhat ironic because 
the participants said that compliance with treatment 
regimens made them feel good personally while only a small 
percentage of the participants reported daily compliance.
The fifth facilitator (64%) to emerge from the Jones 
Hypertension Compliance Survey was, "I understand my 
medications, exercise plan and dietary restrictions 
prescribed by my doctor or nurse practitioner." This 
facilitator was consistent with the study conducted by 
Bonner and Carr (2002) that suggested the importance of 
practitioners being aware of patients' comprehension and 
communication levels to improve medication compliance.
This basically validates that it is extremely important to 
openly communicate with patients in order to incorporate 
an effective treatment regimen. Facilitator number seven
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(26%), "I understand how important it is to take my 
medications, so I take my medications every day," was 
confirmed in a study by Benson and Britten (2002) . The 
researchers found as a result of their study that 50% of 
people diagnosed as having hypertension do not take their 
prescribed medication. The lower percentage in the current 
study could be attributed to the sample population as well 
as the number and cost of prescribed medications.
The sixth (46%) and eighth (24%) facilitators are "I 
exercise for at least 30 minutes 3-4 times each week" and 
"I read the labels on foods to find out the amount of 
sodium (salt), fat, and cholesterol," respectively. Bonner 
and Carr (2002) suggest that so many facets of the 
patient's lifestyle require permanent adjustment, true 
compliance becomes a serious issue. Mallion and Schmitt 
(2001) stated that few patients are compliant in all 
necessary areas. "My doctor or nurse practitioner will 
praise me if I follow my prescribed treatment plan" is the 
ninth (20%) and final identified facilitator. A study by 
Gabriel et al. (1997) supported this facilitator in 
finding that good communication of instructions and 
information to patients decrease drug errors and promote 
better compliance. Benson and Britten (2002) also found 
support for this facilitator. Their study revealed that by 
talking to the patient and considering their views when
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initiating antihypertensive treatment that compliance 
could be improved. These findings can be summed up by 
saying a little encouragement can ignite a pathway to 
motivation.
The number one barrier identified in this group was, 
"I do not like having to take medication every day or I 
forget to take my medicine." This is reflective of 
internal personal beliefs concerning the importance of 
health-promoting behaviors and the personal worth which 
would enhance the patient's actions. This was also found 
in a study conducted by Benson and Britten (2002) . In 
their study 7 6% of the patients in their study expressed 
some reservation concerning taking medications. "I do not 
like to exercise" and "I can't eat my food without salt 
and a little salt won't hurt" were the next rated 
barriers, 48% and 34%, respectively. Hayes (2001) reports 
that lack of information related to the disease process, 
treatment plan, expectations, and medications is a primary 
reason for lack of compliance. Barrier number five (26%), 
"It doesn't hurt if I miss a few doses of my medications," 
is also supported by Hayes (2001).
Allen (2002) reported a direct correlation between 
transportation and money when studying compliance issues. 
This is a reflection on barriers four (30%), eight (12%), 
and nine (8%), respectively: "I can't afford the low-fat.
47
low-sodium, or low-cholesterol foods on my diet plan," "I 
don't have the money/insurance to pay for my medications," 
and "Sometimes I don't have transportation to pick up my 
medications." The sixth (24%) and seventh (18%) barriers 
were, "I'm too tired or sick to exercise" and "My blood 
pressure medications make me feel bad." These findings 
could be attributed to co-morbid conditions or because of 
lack of compliance with antihypertensive medications. 
Gallup and Cotugno (1986) discovered that 11% of patients 
treated for hypertension stopped their medicines because 
of undesirable side effects.
Conclusions
Based upon the statistical findings from this study, 
the following conclusions were made:
1. The number one facilitator to compliance in 
hypertensive middle-aged African-American adults 
is, "I have transportation to pick up my 
medications from the pharmacy."
2. The number one barrier to compliance in 
hypertensive middle-aged African-American adults 
is, "I do not like to take medication every day or 
I forget to take my medicine."
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3. Hypertensive middle-aged African-American adults 
perceive more facilitators than barriers to 
compliance.
4. Perceived barriers of African-American adults are 
internal instead of external factors.
Implications for Nursing
A number of implications for nursing were derived 
from this study. Implications are proposed for nursing 
practice, education, administration, theory, and research.
Nursing practice. Because this devastating condition 
has such serious consequences, nurse clinicians must 
continue to evaluate reasons for noncompliance. Nurse 
practitioners in primary care are constantly faced with 
the challenge of prescribing hypertensive treatment. It is 
important that health care providers know facilitators and 
barriers to compliance with these treatment regimens. The 
results of this study could provide pertinent insight in 
the problem of noncompliance with hypertension by 
validating perceived facilitators and barriers of 
hypertensive treatment compliance for middle-aged African- 
American adults and thereby improving patient response to 
treatment of this chronic condition. This knowledge can 
prove helpful in designing interventions to assist 
patients in achieving compliance.
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Education. It is vital that nursing programs 
incorporate the importance of assessing facilitators and 
barriers to treatment compliance within course curricula 
at all levels of nursing education. Detail must be focused 
on changing or modifying behaviors to ensure compliance 
with treatment, thus promoting health and compliance. 
Another important educational aspect is that this study 
can provide understanding of patient behavior which can be 
helpful in educating patients on ways of enhancing 
treatment compliance. By understanding patients' perceived 
facilitators and barriers to compliance, nurse 
practitioners can plan education and intervention 
programs.
Administration. Nurse practitioners in the 
administrative role can be instrumental in recognizing the 
need for hypertensive treatment compliance and supporting 
efforts to make those services available. Masters-prepared 
nurses are in a position to communicate to local and state 
government officials the need to bring in needed services 
and educational programs. Advanced practice nurses are 
also prepared to write grants to finance such needs.
Theory. Pender's Health Promotion Model validates the 
need for promoting health through assessment of behaviors 
and beliefs. Therefore, nurse clinicians should consider 
this model as a significant framework choice for practice.
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Pender suggests that individual beliefs about health 
influence the likelihood of participation in health- 
promoting behaviors. Health behaviors are linked to health 
promotion. This is a primary goal for health care 
providers. This study adds to Pender's Health Promotion 
Model and the body of nursing knowledge by supporting that 
a patient's personal beliefs about facilitators and 
barriers to compliance have an influence, either directly 
or indirectly, on participation in health-promoting 
behavior, such as adherence to a prescribed treatment 
regimen.
Research. The increased prevalence of hypertensive 
patients makes it necessary for family nurse practitioners 
and other health care providers to have a working 
knowledge of the issues surrounding compliance. Having a 
better understanding of what facilitates or inhibits 
treatment compliance for this population can foster 
guidance for the most effective treatment strategies to 
manage this chronic condition. This research study can add 
to nursing's body of knowledge to impact the overall goal 
of maintaining tighter control of the disease and 
increasing the quality and longevity of life for 
hypertensive patients.
5 1
Recommendations for Further Research
1. Replication of this study with a larger sample 
size.
2. Development of valid and reliable research tools 
for measuring compliance.
3. Conduction of more research using Pender's Health 
Promotion Model to examine facilitators and 
barriers to compliance of medication treatment.
4. Conduction of more research which incorporates 
teaching/learning strategies that affect 
compliance to medical treatment.
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2 04 South Beauchamp Avenue 
Greenville, MS 38703 
November 25, 2002
Reverend Jesse Jackson, Sr.
New Jerusalem M.B. Church 
518 Gum Street 
Greenville, MS 38701
Dear Reverend Jackson,
I am a graduate student at Mississippi University for Women 
in Columbus, MS, pursuing a Master of Science in Nursing 
with a specialty as a Family Nurse Practitioner. My expected 
date of graduation is August 2003.
The purpose of this letter is to request permission to 
conduct a portion of my nursing research project at New 
Jerusalem M.B. Church. I am attempting to determine 
facilitators and barriers to compliance with hypertension 
treatment among middle-aged African Americans.
I would like to be able to obtain volunteer subjects ranging 
in age from 30 to 50 years from your church. A questionnaire 
consisting of 16 questions will be used to elicit data from 
participants. Confidentiality will be guaranteed to all 
participants who complete the questionnaire.
I would appreciate your assistance in the implementation of 
this project. You may contact me at (662) 378-3019 or (662) 
428-6705 if you have any questions regarding the study. I am 





JONES HYPERTENSIVE COMPLIANCE SURVEY
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Jones Hypertensive Compliance Survey
1. Age:   years Q  a. Male Q  b. Female
2. Height:___________
3. Weight:___________
4 . Marital status
ü  a. Single ü  b . Widowed ü  c. Married
5. Educational level
ü  a. 8̂  ̂grade or less 
Q  b. 9̂  ̂to 12̂  ̂grade 
Ql c. High school graduate 
Q  d. Attended college 
ü  e. Graduated college
6. Annual family income : _______________
7. How long have you had high blood pressure?
8. How long have you been taking high blood pressure medicine?
9. Do you take your high blood pressure medication(s)? 
Ql a. Yes Q b. No
10. Name your high blood pressure medication(s).
11. Are you on a special diet? 
Q  a. Yes Q  b . No
If so, what kind?
12. Do you exercise regularly? 
Q  a. Yes Q  b. No
How many times each week?
What type of exercise do you do?
61
13. Existing health status: I would place my present state of 




14. Following is a list of possible facilitators (make easy) and 
barriers (make difficult) to compliance in hypertensive 
middle-aged African American adults. Check (̂ ) all that 
apply to you.
Q  a. I understand my medications, exercise plan, and
dietary restrictions prescribed by my doctor or nurse 
practitioner.
I understand how important it is to take my 
medications, so I take my medications every day.
I have transportation to pick up my medications from 
the pharmacy.
I have income/insurance to pay for my medications.
I exercise for at least 30 minutes 3-4 times each 
week.
I read the labels on foods to find out the amount of 
sodium (salt), fat, and cholesterol.
I understand how high blood pressure can affect my 
body.
When I take my medications, exercise, or eat according 
to my dietary restrictions, I feel good about myself. 
My doctor or nurse practitioner will praise me if I 
follow my prescribed treatment plan.
I do not like having to take medication every day or I 
forget to take my medicine.
I do not like to exercise.
My blood pressure medications make me feel bad.
It doesn't hurt if I miss a few doses of my 
medications.
Sometimes I don't have transportation to pick up my 
medications.
I don't have the money/insurance to pay for my 
medications.
I'm too tired or sick to exercise.
I can't eat my food without salt and a little salt 
won't hurt.
I can't afford the low-fat, low-sodium, or low- 



















15. What do you think is the greatest facilitator to compliance 
in hypertensive middle-aged African-American adults?
16. What do you think is the greatest barrier to compliance in 
hypertensive middle-aged African-American adults?
THANK YOU FOR YOUR ASSISTANCE IN COMPLETING THIS SURVEY.
PLEASE RETURN THE SURVEY TO THE RESEARCHER.
